193 related articles for article (PubMed ID: 23432536)
1. Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy.
Hoenigl M; Seeber K; Koidl C; Buzina W; Wölfler A; Duettmann W; Wagner J; Strenger V; Krause R
Mycoses; 2013 Jul; 56(4):471-6. PubMed ID: 23432536
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
[TBL] [Abstract][Full Text] [Related]
3. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
[TBL] [Abstract][Full Text] [Related]
4. Serum and urine galactomannan testing for screening in patients with hematological malignancies.
Duettmann W; Koidl C; Troppan K; Seeber K; Buzina W; Wölfler A; Wagner J; Krause R; Hoenigl M
Med Mycol; 2014 Aug; 52(6):647-52. PubMed ID: 24939321
[TBL] [Abstract][Full Text] [Related]
5. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
[TBL] [Abstract][Full Text] [Related]
6. Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.
Eigl S; Prattes J; Reinwald M; Thornton CR; Reischies F; Spiess B; Neumeister P; Zollner-Schwetz I; Raggam RB; Flick H; Buchheidt D; Krause R; Hoenigl M
Int J Antimicrob Agents; 2015 Oct; 46(4):401-5. PubMed ID: 26187363
[TBL] [Abstract][Full Text] [Related]
7. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
[TBL] [Abstract][Full Text] [Related]
8. Hema e-Chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections.
Nosari AM; Caira M; Pioltelli ML; Fanci R; Bonini A; Cattaneo C; Castagnola C; Capalbo SF; De Fabritiis P; Mettivier V; Morselli M; Pastore D; Aversa F; Rossi G; Pagano L;
Clin Microbiol Infect; 2013 Aug; 19(8):757-62. PubMed ID: 23279327
[TBL] [Abstract][Full Text] [Related]
9. Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease.
Affolter K; Tamm M; Jahn K; Halter J; Passweg J; Hirsch HH; Stolz D
Am J Respir Crit Care Med; 2014 Aug; 190(3):309-17. PubMed ID: 25007380
[TBL] [Abstract][Full Text] [Related]
10. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
Danylo A; Courtemanche C; Pelletier R; Boudreault AA
Med Mycol; 2014 Aug; 52(6):577-83. PubMed ID: 25023484
[TBL] [Abstract][Full Text] [Related]
11. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies.
Weisser M; Rausch C; Droll A; Simcock M; Sendi P; Steffen I; Buitrago C; Sonnet S; Gratwohl A; Passweg J; Fluckiger U
Clin Infect Dis; 2005 Oct; 41(8):1143-9. PubMed ID: 16163633
[TBL] [Abstract][Full Text] [Related]
12. Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients.
Couchepin J; Brunel AS; Jaton K; Meylan P; Bochud PY; Lamoth F
Mycoses; 2018 Jun; 61(6):350-354. PubMed ID: 29453853
[TBL] [Abstract][Full Text] [Related]
13. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
Danpornprasert P; Foongladda S; Tscheikuna J
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
[TBL] [Abstract][Full Text] [Related]
14. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis.
Cordonnier C; Botterel F; Ben Amor R; Pautas C; Maury S; Kuentz M; Hicheri Y; Bastuji-Garin S; Bretagne S
Clin Microbiol Infect; 2009 Jan; 15(1):81-6. PubMed ID: 19154482
[TBL] [Abstract][Full Text] [Related]
15. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
Pazos C; Pontón J; Del Palacio A
J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
Pasqualotto AC; Xavier MO; Sánchez LB; de Oliveira Costa CD; Schio SM; Camargo SM; Camargo JJ; Sukiennik TC; Severo LC
Transplantation; 2010 Aug; 90(3):306-11. PubMed ID: 20548265
[TBL] [Abstract][Full Text] [Related]
17. [The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients].
Xie LP; Liu T; Meng WT; Zhou J
Zhonghua Nei Ke Za Zhi; 2006 Dec; 45(12):992-5. PubMed ID: 17326997
[TBL] [Abstract][Full Text] [Related]
18. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.
Hidalgo A; Parody R; Martino R; Sánchez F; Franquet T; Giménez A; Blancas C
Eur J Radiol; 2009 Jul; 71(1):55-60. PubMed ID: 18468830
[TBL] [Abstract][Full Text] [Related]
19. Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies.
Jha AK; Bansal D; Chakrabarti A; Shivaprakash MR; Trehan A; Marwaha RK
Mycoses; 2013 Jul; 56(4):442-8. PubMed ID: 23369047
[TBL] [Abstract][Full Text] [Related]
20. Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients.
Park SH; Choi SM; Lee DG; Choi JH; Kim SH; Kwon JC; Yoo JH; Kim HJ; Lee S; Eom KS; Min WS
Mycoses; 2011 Nov; 54(6):523-30. PubMed ID: 21605195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
